Kommentar zu den Leitlinien (2023) der ESC zum Akuten Koronarsyndrom (ACS)

被引:0
作者
Wassmann, Sven [1 ,2 ]
Gimenez, Maria Rubini [3 ]
Cassese, Salvatore [4 ]
Ghanem, Alexander [5 ]
Schuepke, Stefanie [6 ]
Ong, Peter [7 ]
Schirmer, Stephan Henrik [8 ]
Thiele, Holger [3 ]
Mehilli, Julinda [9 ,10 ]
机构
[1] Herzpraxis Pasing, Munich, Germany
[2] Univ Saarland, Med Fak, Inst Str 14, D-81241 Munich, Germany
[3] Herzzentrum Leipzig, Univ Klin Kardiol, Leipzig, Germany
[4] Deutsch Herzzentrum Munich, Klin Herz & Kreislauferkrankungen, Munich, Germany
[5] Asklepios Klin Nord Heidberg, Innere Med 2, Hamburg, Germany
[6] Privatpraxis Kardiol, Frankfurt Main, Germany
[7] Robert Bosch Krankenhaus, Abt Kardiol & Angiol, Stuttgart, Germany
[8] Kardiopraxis Schirmer, Kaiserslautern, Germany
[9] Krankenhaus Landshut Achdorf, Med Klin 1, Landshut, Germany
[10] Deutsch Gesell Kardiol, Kommiss Klin Kardiovaskulare Med, Dusseldorf, Germany
来源
KARDIOLOGIE | 2024年 / 18卷 / 06期
关键词
Secondary prevention; Acute chest pain; Anticoagulation; Antiplatelet therapy; Cardiac revascularisation; ST-SEGMENT ELEVATION; ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; TASK-FORCE; GUIDELINES; CARDIOLOGY; TICAGRELOR; PRASUGREL; OLDER;
D O I
10.1007/s12181-024-00705-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current 2023 European Society of Cardiology (ESC) guidelines on acute coronary syndromes (ACS) describe ACS as a disease spectrum and, therefore, for the first time combine the recommendations for the management of patients with ST-elevation myocardial infarction and non-ST-elevation ACS in one set of guidelines. The guidelines have evaluated new treatment concepts and extensive study data and provide, among others, recommendations for an individualized antithrombotic treatment, timing and completeness of myocardial revascularisation, the importance of intracoronary imaging and physiology, myocardial infarction with non-obstructive coronary arteries (MINOCA) as well as special clinical situations. Furthermore, they underline the importance of secondary prevention and the inclusion of patients in treatment decisions. Overall, these very comprehensive guidelines provide clear recommendations on the diagnostics, initial management, invasive and revascularisation strategies as well as on non-pharmacological and pharmacological treatment of patients with ACS in the acute phase, the period of the first 12 months after ACS and especially for long-term treatment.
引用
收藏
页码:458 / 469
页数:12
相关论文
共 31 条